|
PI Principal Investigator
- An Open-Label, Large Simple Usual Care Study of the Effect of Adding Rofecoxib 50 mg to a Regimen of Selected Opioid Analgesic PRN in Patients Undergoing Selected Outpatient Surgical Knee Arthroscopy Procedures. Merck & Co., Inc., 04/03 to 07/04.
- A Phase 2 Randomized, Double-Blinded (BMS-562247 and enoxaparin), Active-Controlled (enoxaparin and warfarin), Parallel-Arm, Dose-Response Study of the Oral Factor Xa Inhibitor BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery. Bristol-Myers Squibb Company, 11/04 to present.
- PMA PostApproval Study for DURALOC Option Ceramic-on-Ceramic Hip Prosthesis System. (DePuy) Sub-Investigator
- Flexibility in Administration of Arixtra for Prevention of Symptomatic Venous Thromboembolism in Orthopedic Surgery. Organon Sanofi-Synthelabo, 09102 to 02/04.
- DAP-OST-06-02: "A Phase 2 Randomized Study Investigating the Safety, Efficacy and Pharmacokinetics ofDaptomycin 6 mg/kg and 8 mglkg versus Comparator (Vancomycin or Teicoplanin) in the Treatment of Subjects Undergoing Surgical Standard of Care for Osteomyelitis Associated with an Infected Prosthetic Hip or Knee Joint caused by Methicillin-reisistant Staphylococcus aureus and/or Coagulase-negative staphylococci" (Cubist Pharmaceuticals, Inc.)
- SCRIHS # 06-157, Orthopaedic Registry.
- OP-l Implant. Stryker Biotech, 3/03 to present -a safety and efficacy study with the use of OP-l for patients who have trouble healing a broken bone. Humanitarian Device.
- Unicompartmental Knee Arthroplasty: Prospective Multi-Center Clinical Outcomes Study. (Zimmer) VerSys Hip System Clinical Study Protocol. (Zimmer). NexGen Complete Knee Solution Clinical Study Protocol. (Zimmer)
- Investigator Initiated. Trace Metal Analysis in Patients Treated with Volar Distal Radial Plates for Unstable Fractures of the Distal Radius.
|
